Increase of regulatory T cells in the peripheral blood of cancer patients

Clinical Cancer Research

Volumn 9, Issue 2, 2003, Pages 606-612

  Wolf, Anna Maria ^a,c   Wolf, Dominik ^b   Steurer, Michael ^b   Gastl, Guenther ^b   Gunsilius, Eberhard ^b   Grubeck Loebenstein, Beatrix ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c NONE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ARTICLE; BLOOD; CANCER; CELL PROLIFERATION; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR MODEL;

ANTIGENS, CD; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPHOCYTE COUNT; NEOPLASM STAGING; NEOPLASMS; REFERENCE VALUES; STOMACH NEOPLASMS; T-LYMPHOCYTES;

EID: 0037312480     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Strand, S., and Galle, P. R. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications. Mol. Med. Today, 4: 63-68, 1998.
2. Kaklamanis, L., Townsend, A., Doussis-Anagnostopoulou, I. A., Mortensen, N., Harris, A. L., and Garter, K. C. Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am. J. Pathol., 145: 505-509, 1994.
3. Elgert, K. D., Alleva, D. G., and Mullins, D. W. Tumor-induced immune dysfunction: the macrophage connection. J. Leukoc. Biol., 64: 275-290, 1998.
4. Staveley-O'Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D., and Levitsky, H. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression. Proc. Natl. Acad. Sci. USA, 95: 1178-1183, 1998.
5. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol., 155: 1151-1164, 1995.
6. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., and Enk, A. H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med., 193: 1285-1294, 2001.
7. Dieckmann, D., Plottner, H., Berchtold, S., Berger, T., and Schuler, G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med., 193: 1303-1310, 2001.
8. Ng, W. F., Duggan, P. J., Ponchel, F., Matarese, G., Lombardi, G., Edwards, A., Isaacs, J., and Lechler, R. I. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood, 98: 2736-2744, 2001.
9. Stephens, L. A., Mottet, C., Mason, D., and Powrie, F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol., 31: 1247-1254, 2001.
10. Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J., and Enk, A. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol., 27: 3135-3142, 1997.
11. Hatam, L., Schuval, S., and Bonagura, V. R. Flow cytometric analysis of natural killer cell function as a clinical assay. Cytometry, 16: 59-68, 1994.
12. Taams, L. S., Smith, J., Rustin, M. H., Salmon, M., Poulter, L. W., and Akbar, A. N. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol., 31: 1122-1131, 2001.
13. Cerwenka, A., and Lanier, L. L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol., 1: 41-49, 2001.
14. Shimizu, J., Yamazaki, S., and Sakaguchi, S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol., 163: 5211-5218, 1999.
15. Steitz, J., Bruck, J., Lenz, J., Knop, J., and Tuting, T. Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon α-induced. CD8(+) T-cell-dependent immune defense of B 16 melanoma. Cancer Res., 61: 8643-8646, 2001.
16. Onizuka, S., Tawara, I., Shimizu, J., Sakaguchi, S., Fujita, T., and Nakayama, E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res., 59: 3128-3133, 1999.
17. Woo, E. Y., Chu, C. S., Goletz, T. J., Schlienger K, Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., and June, C. H. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res., 61: 4766-4772, 2001.
18. Woo, E. Y., Yeh, H., Chu, C. S., Schlienger, K., Carroll, R. G., Riley, J. L., Kaiser, L. R., and June, C. H. Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J. Immunol., 168: 4272-4276, 2002.
19. Nakamura, K., Kitani, A., and Strober, W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med., 194: 629-644, 2001.
20. Sutmuller, R. P., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T., Wildenberg, M., Allison, J., Toes, R., Offringa, R., and Melief, C. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med., 194: 823-832, 2001.
21. Thornton, A. M., and Shevach, E. M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol., 164: 183-190, 2000.